Table 2.
Target | Microinjection | p-value | Treatment | p-value | Micro.*Treat. | p-value |
---|---|---|---|---|---|---|
| ||||||
Eotaxin | F(1,23) = 6.522 | p = 0.0178 | F(1,23) = 0.0008 | ns | F(1,23) = 0.247 | ns |
IFNγ | F(1,23) = 5.177 | p = 0.0325 | F(1,23) = 0.8085 | ns | F(1,23) = 0.0844 | ns |
IL-13 | F(1,23) = 5.569 | p = 0.0271 | F(1,23) = 1.647 | ns | F(1,23) = 0.5017 | ns |
IL-4 | F(1,23) = 0.0227 | ns | F(1,23) = 11.29 | p = 0.0027 | F(1,23) = 1.264 | ns |
VEGF | ||||||
GM-CSF | F(1,23) = 3.045 | p = 0.0943 | F(1,23) = 7.172 | p = 0.0134 | F(1,23) = 0.7248 | ns |
CXCL5 | F(1,23) = 5.783 | p = 0.0246 | F(1,23) = 2.977 | p = 0.0979 | F(1,23) = 0.2292 | ns |
CXCL2 | F(1,23) = 5.452 | p = 0.0286 | F(1,23) = 3.775 | p = 0.0644 | F(1,23) = 0.612 | ns |
IL-6 | F(1,21) = 16.61 | p = 0.0005 | F(1,21) = 5.814 | p = 0.0251 | F(1,21) = 1.893 | ns |